Safety and efficacy of aprepitant as mono and combination therapy for the prevention of emetogenic chemotherapy-induced nausea and vomiting: post-marketing surveillance in China.
Yang Y, Yang N, Wu L, Ouyang Q, Fang J, Li J, Liao W, Cai K, Huang J, Li J, Zhang Y, Wang X, Zhang H, Xu N, Zhao Q, Hu X, Li W, Zhong W, Zhong D, Cheng G, Ye S, Zhong M, Wang D, Liu H, Zheng J, Liu X, Xu H, Zhang L.
Yang Y, et al. Among authors: li j, li w.
Chin Clin Oncol. 2020 Oct;9(5):68. doi: 10.21037/cco-20-160.
Chin Clin Oncol. 2020.
PMID: 33161724
Free article.